Immune checkpoint inhibitor-induced musculoskeletal manifestations. A multicentre prospective study

Immune checkpoint inhibitor-induced musculoskeletal manifestations. A multicentre prospective study

Background: Immune checkpoint inhibitors (ICI) are anti-cancer drugs that act by enhancing anti-tumour immunity. Due to their mechanism of action, they have been associated with immune related adverse events (Ir-AE), including musculoskeletal manifestations. Aim: To assess a) the prevalence, clinica...

Full description

Bibliographic Details
Main Authors: Dimitrios Daoussis, Konstantinos Melissaropoulos, Theodoros Dimitroulas, Haralambos Andreadis, Athina Christopoulou, George Douganiotis, Thomas Makatsoris, Angelos Koutras, Panagiotis Georgiou, Haralabos Kalofonos
Format: Article
Language:English
Published: PCO Convin S.A. 2020-01-01
Series:Mediterranean Journal of Rheumatology
Subjects:
immune checkpoint inhibitors
musculoskeletal
arthritis
rheumatic
cancer immunotherapy
anti-pd-1
anti-ctla4
Online Access:http://www.mjrheum.org/assets/files/792/file235_1182.pdf

Internet

http://www.mjrheum.org/assets/files/792/file235_1182.pdf

Similar Items